ASHG 2026 has ended. This guide stays up as the record of who was there. Next: ASHG 2027, Oct 26–30, 2027 in Nashville
University of Alabama at Birmingham at ASHG 2026
Oct 20–24, 2026 Montréal, Canada ~7.5k attendees Website
University of Alabama at Birmingham brings 8 presentations from 5 research groups to ASHG 2026 in Montréal. Its program centres on rare disease, population genetics and computational and clinical approaches to therapeutics. McDonald Laboratory of Integrative 'Omics brings Million Veteran Program studies of hip osteoarthritis, Center for Computational Genomics and Data Science brings genetic modifiers in pulmonary arterial hypertension, and Genomic Medicine & Program for Translational Pharmacogenomics brings pharmacogenomics in clinical care.
| Organization | ASHG 2026 Attendance |
|---|---|
University of Alabama at Birmingham Birmingham, Alabama | 3 PhD Students · 2 Faculty |
McDonald Laboratory of Integrative 'Omicssites.uab.edu/mcdonaldlab/home/people Integrates gene, transcript, protein and metabolite data with deep disease phenotyping. Studies COPD, osteoarthritis and joint replacement, including work in the Million Veteran Program.
| Poster Wed Oct 21 2:30 pm Candidate DNA repair genes associated with cognitive outcomes in Head and Neck Cancer CancerCandidate geneBrain/nervous system Poster Thu Oct 22 4:15 pm Pathway analysis identified biological mechanisms of hip osteoarthritis in the Million Veteran Program Complex traitsExpression quantitative trait lociGenome-wide association studyTranscriptome Poster Fri Oct 23 2:30 pm Spatial Transcriptomics of Skeletal Muscle in COPD and COPD Cachexia Reveal Dysregulation in Intracellular Communication and Mitochondrial Dysfunction Spatial transcriptomicsMuscular abnormalitiesComplex diseasesMitochondria |
Center for Computational Genomics and Data Sciencesites.uab.edu/cgds Analyzes whole genome sequencing, RNA-seq, multi-omic profiling and clinical data with computational genomics tools. Supports rare-disease diagnosis, variant prioritization and precision medicine.
| Poster Wed Oct 21 2:30 pm Integrative multi-omics reveals regulatory network rewiring and candidate genetic modifiers in heritable pulmonary arterial hypertension Exome/genome sequencingGene regulationRare variantsRNA-seq Session Fri Oct 23 9:45 am |
Genomic Medicine & Program for Translational Pharmacogenomicsidm.uab.edu/cgi-bin/dir/query?key=GPZVFMAH&pop=1 Analyzes genotype, clinical and drug-response data with candidate-gene, genome-wide association and exome approaches. Applies genotype-guided therapy to anticoagulant and antiplatelet response across UAB clinical care.
| Poster Wed Oct 21 2:30 pm Precision Medicine for Brain Health: Early Experience Implementing Pharmacogenomics Across Three Clinical Settings at a Large Academic Institution PharmacogenomicsClinical testingBrain/nervous system |
Hugh Kaul Precision Medicine Instituteuab.edu/medicine/pmi/about/leadership-team Uses AI, bioinformatics, genomic engineering, lab science and mediKanren to study genetic disorders. Develops therapeutic strategies with patients, families, clinicians and researchers.
| Poster Wed Oct 21 2:30 pm Near-term Impact of Type 2 Polygenic Risk Score Disclosure on Glycemic Monitoring and Treatment: The Electronic Medical Records and Genomics Study Complex diseasesDiabetesElectronic health recordsPolygenic risk score |
Limdi Laboratory Works in clinical genetics and therapeutics. | Poster Thu Oct 22 4:15 pm Ancestry- and sex-specific pharmacogenomic architecture of warfarin-associated hemorrhage PharmacogenomicsMetabolomics |
| 2 more presenters — research group not yet identified | |
Find decision makers at University of Alabama at Birmingham
Tell us what you sell and we’ll find the people at University of Alabama at Birmingham most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Human Genetics. Submit a correction